Clinical Trial Update: Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias [Phase 4]

View source ↗

Summary

Phase 4 trial assessing long-term safety and efficacy of Ferriprox in iron-overloaded patients, including those with sickle cell disease and other anemias; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Other Anemias
• Sickle Cell Disease

Drugs mentioned

• FERRIPROX (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Iron Overload, Sickle Cell Disease | Phase 4 | Status: TERMINATED | Results posted: 2024-01-10